Clinical and genetic association, radiological findings and response to biological therapy in seven children from Qatar with non‐bacterial osteomyelitis

Abstract

Non-bacterial osteomyelitis may coexist with other autoinflammatory diseases. MRI remains a favorable diagnostic tool and genetic testing may have a limited role in selected cases. Infliximab and canakinumab are associated with variable outcomes, and 6-week or less dosing intervals for both medications may be more effective.